Operating income increased 3.3%
Operating income changed +3.3% from the comparable as-filed period. The change ranks at the 28th percentile of 144 prior comparable changes.
$3.2B→$3.3B144 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MCD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 21 bp lower
Operating margin changed -21 basis points from the comparable as-filed period. The change ranks at the 11th percentile of 144 prior comparable changes.
47.23%→47.02%144 prior comparisons
Revenue increased 3.7%
Revenue changed +3.7% from the comparable as-filed period. The change ranks at the 44th percentile of 144 prior comparable changes.
$6.8B→$7.1B144 prior comparisons
Cash & equivalents decreased 56.2%
Cash & equivalents changed -56.2% from the comparable as-filed period. The change ranks at the 70th percentile of 320 prior comparable changes.
$1.9B→$822.0M320 prior comparisons
Free-cash-flow proxy increased 57.6%
Free-cash-flow proxy changed +57.6% from the comparable as-filed period. The change ranks at the 92th percentile of 144 prior comparable changes.
$1.3B→$2.0B144 prior comparisons
Operating cash flow increased 40.5%
Operating cash flow changed +40.5% from the comparable as-filed period. The change ranks at the 90th percentile of 144 prior comparable changes.
$2.0B→$2.8B144 prior comparisons
Selling, general & administrative increased 16.7%
Selling, general & administrative changed +16.7% from the comparable as-filed period. The change ranks at the 100th percentile of 93 prior comparable changes.
$700.0M→$817.0M93 prior comparisons
Capital expenditure increased 11.7%
Capital expenditure changed +11.7% from the comparable as-filed period. The change ranks at the 47th percentile of 144 prior comparable changes.
$744.0M→$831.0M144 prior comparisons
Capex / revenue moved 83 bp higher
Capex / revenue changed +83 basis points from the comparable as-filed period. The change ranks at the 42th percentile of 144 prior comparable changes.
10.87%→11.71%144 prior comparisons
Inventory increased 5.5%
Inventory changed +5.5% from the comparable as-filed period. The change ranks at the 43th percentile of 128 prior comparable changes.
$55.0M→$58.0M128 prior comparisons
Stock-based compensation decreased 11.4%
Stock-based compensation changed -11.4% from the comparable as-filed period. The change ranks at the 47th percentile of 144 prior comparable changes.
$44.0M→$39.0M144 prior comparisons
Net income increased 4.8%
Net income changed +4.8% from the comparable as-filed period. The change ranks at the 31th percentile of 144 prior comparable changes.
$2.3B→$2.4B144 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.